PapersFlow Research Brief
Safe Handling of Antineoplastic Drugs
Research Guide
What is Safe Handling of Antineoplastic Drugs?
Safe handling of antineoplastic drugs refers to the protocols and practices implemented by healthcare workers to minimize occupational exposure to cytotoxic chemotherapy agents through measures like surface decontamination, biological monitoring, closed-system protective devices, and adherence to safety guidelines.
Research on safe handling of antineoplastic drugs addresses occupational exposure risks for healthcare workers, including surface contamination and genotoxic effects, with 14,180 works published in the field. Falck et al. (1979) detected mutagenicity in urine of nurses handling cytostatic drugs, indicating direct biological risks from exposure. Nussbaumer et al. (2011) reviewed analytical methods for anticancer drugs, supporting environmental monitoring essential to safe handling practices.
Topic Hierarchy
Research Sub-Topics
Surface Contamination by Antineoplastic Drugs
This sub-topic measures wipe samples and determinants of drug residues on work surfaces in pharmacies and hospitals. Researchers study cleaning efficacy and contamination mapping.
Biological Monitoring of Healthcare Workers
Examines biomarkers in urine and blood of personnel handling cytotoxics for exposure assessment. Studies correlate internal doses with handling practices and PPE use.
Closed-System Transfer Devices
Evaluates CSTDs like PhaSeal and ChemoClave for preventing aerosol and liquid escape during compounding. Research compares performance, usability, and cost-effectiveness.
Genotoxic Effects of Occupational Exposure
Investigates DNA damage, chromosomal aberrations, and micronuclei in exposed workers. Studies assess long-term mutagenic risks and dose-response relationships.
Adherence to Antineoplastic Safety Guidelines
Analyzes compliance with NIOSH and ASHP guidelines in handling practices via audits and surveys. Researchers identify barriers and training interventions.
Why It Matters
Safe handling practices directly protect healthcare workers from genotoxic effects and reproductive health risks associated with antineoplastic drug exposure in pharmacies and hospitals. Falck et al. (1979) found mutagenicity in the urine of nurses handling cytostatic drugs, demonstrating measurable biological impact on personnel with 460 citations highlighting its influence. These protocols, including closed-system devices and surface monitoring, reduce contamination levels, as evidenced by studies on pharmacy personnel, enabling safer administration of therapies that treat millions of cancer patients annually without endangering caregivers.
Reading Guide
Where to Start
"MUTAGENICITY IN URINE OF NURSES HANDLING CYTOSTATIC DRUGS" by Falck et al. (1979), as it provides foundational evidence of biological risks from exposure, making it accessible for understanding core occupational hazards.
Key Papers Explained
Falck et al. (1979) in "MUTAGENICITY IN URINE OF NURSES HANDLING CYTOSTATIC DRUGS" establishes direct genotoxic evidence from nurse exposure, which Nussbaumer et al. (2011) in "Analysis of anticancer drugs: A review" builds upon by detailing analytical detection methods for monitoring. Rutala and Weber (2008) in "Guideline for disinfection and sterilization in healthcare facilities, 2008" complements these by offering disinfection protocols applicable to contaminated surfaces, while Garner (1996) in "Guideline for Isolation Precautions in Hospitals" extends precautions to handling contexts.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current research continues to emphasize biological monitoring and closed-system devices for pharmacy personnel, with focus on genotoxic effects and surface decontamination protocols derived from established guidelines like those in Rutala and Weber (2008).
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Disposition of Toxic Drugs and Chemicals in Man | 1982 | — | 1.8K | ✕ |
| 2 | International Conference on Harmonisation | 2014 | Elsevier eBooks | 1.5K | ✕ |
| 3 | Guideline for disinfection and sterilization in healthcare fac... | 2008 | Infection Control and ... | 1.4K | ✕ |
| 4 | European Pharmacopoeia | 1976 | Food and Cosmetics Tox... | 730 | ✕ |
| 5 | Guideline for Isolation Precautions in Hospitals | 1996 | Infection Control and ... | 596 | ✕ |
| 6 | Disposition of Toxic Drugs and Chemicals in Man | 1983 | Forensic Science Inter... | 566 | ✕ |
| 7 | Analysis of anticancer drugs: A review | 2011 | Talanta | 544 | ✕ |
| 8 | Cytotoxicity of 35 dental resin composite monomers/additives i... | 1998 | Journal of Biomedical ... | 506 | ✕ |
| 9 | MUTAGENICITY IN URINE OF NURSES HANDLING CYTOSTATIC DRUGS | 1979 | The Lancet | 460 | ✕ |
| 10 | CyclodextrinsEnabling Excipients: Their Present and Future Use... | 1997 | Critical Reviews in Th... | 417 | ✕ |
Frequently Asked Questions
What are the main risks of handling antineoplastic drugs for healthcare workers?
Healthcare workers face occupational exposure to antineoplastic drugs leading to surface contamination and genotoxic effects. Falck et al. (1979) identified mutagenicity in urine samples from nurses handling cytostatic drugs. Biological and environmental monitoring are used to assess and mitigate these risks.
How is exposure to antineoplastic drugs monitored?
Exposure is monitored through biological monitoring of urine for mutagenicity and environmental monitoring of surfaces for contamination. Falck et al. (1979) demonstrated mutagenicity in nurses' urine after handling cytostatic drugs. Analytical methods reviewed by Nussbaumer et al. (2011) enable detection of anticancer drug residues.
What role do closed-system devices play in safe handling?
Closed-system protective devices prevent aerosol and surface contamination during antineoplastic drug preparation and administration. They are a key component of safety guidelines for pharmacy personnel and healthcare workers. Research emphasizes their use to reduce occupational exposure risks.
What did Falck et al. (1979) find about nurses handling cytostatic drugs?
Falck et al. (1979) reported mutagenicity in the urine of nurses handling cytostatic drugs, indicating genotoxic exposure. The study, published in The Lancet with 460 citations, underscores biological risks. It supports the need for improved handling practices.
Why is adherence to safety guidelines important for antineoplastic drugs?
Adherence to safety guidelines minimizes occupational exposure and protects reproductive health of healthcare workers. Studies highlight persistent surface contamination without proper protocols. Guidelines integrate monitoring and protective equipment to reduce risks.
Open Research Questions
- ? How effective are current closed-system devices in preventing surface contamination by specific antineoplastic agents across diverse healthcare settings?
- ? What are the long-term genotoxic and reproductive health outcomes for healthcare workers with chronic low-level exposure to antineoplastic drugs?
- ? Which combinations of decontamination methods most reliably eliminate antineoplastic drug residues from workplace surfaces?
- ? How does adherence to safety guidelines vary among pharmacy personnel, and what factors predict compliance?
Recent Trends
The field encompasses 14,180 works on occupational exposure, surface contamination, and safety guidelines for antineoplastic drugs, with highly cited papers like Falck et al. at 460 citations and Nussbaumer et al. (2011) at 544 citations driving focus on biological monitoring and analytical detection.
1979Research Safe Handling of Antineoplastic Drugs with AI
PapersFlow provides specialized AI tools for Health Professions researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Safe Handling of Antineoplastic Drugs with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Health Professions researchers